Medical Science Liaison – AML/Hematology (Midwest-Central)

IQVIA; New Orleans (LA); On-site; USD 170,000 - 210,000; Full time

Job summary

IQVIA is seeking experienced Medical Science Liaisons to support a late-stage AML program. The MSL will engage with investigators, hematologists, and oncologists, serving as a scientific resource for data exchange and methodological insights across the territory.

Responsibilities include building relationships with KOLs and institutions, communicating complex data to diverse audiences, and supporting educational activities and investigator-initiated studies. Travel up to 70% is required.

Qualifications

• Advanced clinical or scientific degree required; PharmD, MD, DO, PhD, DNP, NP, PA or equivalent.
• Minimum of 4 years MSL experience or relevant clinical experience in hematology/oncology.
• Minimum 3 years in hematology/oncology with therapeutic expertise.
• Strong ability to communicate complex data to diverse audiences.
• Willingness to travel up to 70% within the assigned territory.

Responsibilities

• Develop and maintain scientific relationships with key opinion leaders and investigators across the territory.
• Engage in compliant, peer-to-peer scientific discussions on AML and hematologic malignancies.
• Communicate complex clinical information clearly to physicians, researchers, and care teams.
• Support disease-state education programs, advisory boards, and investigator meetings.
• Identify medical education needs and provide technical support for study development.
• Maintain clinical expertise through conferences and journals and stay updated on guidelines.

Education

Advanced degree

Tools

CRM platforms

Microsoft Teams

Microsoft Office

Job description

IQVIA is seeking experienced Medical Science Liaisons to support a late-stage AML program. The MSL will engage with investigators, hematologists, and oncologists, serving as a scientific resource for data exchange and methodological insights across the territory.

Responsibilities include building relationships with KOLs and institutions, communicating complex data to diverse audiences, and supporting educational activities and investigator-initiated studies. Travel up to 70% is required.